Aplasia in Chronic Phase CML Post-TKI Therapy: A Management Dilemma

Transient cytopenias and bone marrow hypoplasia commonly occur during treatment of CML with TKIs (tyrosine kinase inhibitors). This is usually related to the eradication of CML clones that initially compose the majority of hematopoietic cells in the bone marrow at the time of diagnosis. With continu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramdial, Jeremy L., Aguirre, Luis E., Ali, Robert A., Swords, Ronan, Goodman, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778880/
https://www.ncbi.nlm.nih.gov/pubmed/31662918
http://dx.doi.org/10.1155/2019/4861673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778880/
https://www.ncbi.nlm.nih.gov/pubmed/31662918
http://dx.doi.org/10.1155/2019/4861673

Ejemplares similares